AMPH
Amphastar Pharma (AMPH) P/E Ratio
P/E Ratio as of Oct 30, 2026: 16.25
Average15.25
Median15.20
Minimum14.73
Maximum16.25
16.25
0.61 (3.90%)past month
The P/E ratio for Amphastar Pharma (AMPH) is 16.25 as of Oct 30, 2026. This represents a increase of 38.89% compared to its 12-month average P/E ratio of 11.7. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Amphastar Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Amphastar Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Amphastar Pharma to industry peers.
Amphastar Pharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Amphastar Pharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Amphastar Pharma to industry peers.
Amphastar Pharma (AMPH) P/E Ratio Insights
See Amphastar Pharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Amphastar Pharma (AMPH)
Order type
Buy in
Order amount
Est. shares
0 shares
Amphastar Pharma (AMPH) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $25.35 | 14.86 |
| Sep 1, 2026 | $22.96 | 13.46 |
| Aug 3, 2026 | $20.22 | 12.15 |
| Jul 1, 2026 | $20.10 | 12.07 |
| Jun 1, 2026 | $18.42 | 11.06 |
| May 1, 2026 | $21.88 | 10.76 |
| Apr 1, 2026 | $20.24 | 9.95 |
| Mar 2, 2026 | $21.01 | 10.33 |
| Feb 2, 2026 | $27.92 | 12.38 |
| Jan 2, 2026 | $26.46 | 11.73 |
Amphastar Pharma (AMPH) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 16.25 | +36.90% |
| 2025 | 11.87 | -3.89% |
| 2024 | 12.35 | -48.86% |
| 2023 | 24.15 | +28.25% |
| 2022 | 18.83 | +0.59% |
| 2021 | 18.72 | — |
FAQs About Amphastar Pharma (AMPH) P/E ratio
The latest P/E ratio of Amphastar Pharma (AMPH) is 16.25, as of Oct 30, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Amphastar Pharma’s last 12-month average P/E ratio is 11.7, compared to its current P/E ratio of 16.25. This reflects a increase of 38.89%.
Amphastar Pharma’s current P/E ratio of 16.25 is higher than its last 12-month average P/E of 11.7. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Amphastar Pharma’s average P/E ratio over the last 3 years is 13.13. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Amphastar Pharma’s average P/E ratio over the last 5 years is 16.7. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Amphastar Pharma (AMPH) P/E Ratio Insights
See Amphastar Pharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Amphastar Pharma (AMPH)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.